16:00 EST Vincerx Pharma (VINC) Inc trading halted, news pending See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investmen ...

The Japanese pharma, maker of Alzheimer’s disease med Leqembi, remains “fully committed” to the U.S. market, a company spokesperson said. 2. China puts former NMPA deputy director under ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

The "Directory of Pharmaceutical Venture Capital & Private Equity Firms 2025" has been added to ResearchAndMarkets.com's offering. The Directory of Pharmaceutical Venture Capital & Private Equity ...

The "Middle East Pharmaceutical Directory 2025" directory has been added to ResearchAndMarkets.com's offering. The market potential of the Middle East pharmaceutical and biotechnology sector is ...

TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...

Regular physical activity slows the accumulation of p-tau181, a key Alzheimer’s biomarker, but its cognitive benefits ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of $300.00. The company’s shares closed yesterday at $245.20.

RIO DE JANEIRO, Feb 26 (Reuters) - Brazil's Petrobras (PETR4.SA), opens new tab posted a net loss of 17 billion reais ($2.8 billion) in its fourth quarter due to non-recurring events, lower Brent ...

The Commission on Elections (Comelec) announced on Monday that official ballots for the Bangsamoro parliamentary elections will include candidates’ photos and the official logos of political parties. ...

United States President Donald Trump has announced his intention to impose tariffs of approximately 25 percent on imports of automobiles, semiconductors, and pharmaceuticals, with the announcement ...